NICE Rapid Guidelines May 2020
There have been four rapid guidelines and evidence reviews and two evidence summaries related to COVID-19 published in May 2020 by the National Institute for Clinical Excellence which has impact upon primary care.
The COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders guideline has been updated and published. The updated guideline highlights factors to consider when considering temporarily stopping some drugs for children and young people.
The COVID-19 rapid guideline: children and young people who are immunocompromised guideline has been updated and published. The update aims to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic.
The COVID-19 rapid guideline: chronic kidney disease guideline has been updated and published. The update aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic.
The COVID-19 rapid guideline: interstitial lung disease guideline has been updated and published. It aims to maximise the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic.
The COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 evidence summary has been published. This analysis found two observational studies that were of poor quality and subject to bias and confounding. As such conclusions cannot be drawn without further research.
The COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 evidence summary has been published. A literature search identified no evidence from published scientific studies. However, it is noted that NSAIDs and COVID-19 can both contribute to respiratory, cardiovascular, and renal complications.
Clinicians should be aware of these guidelines and implement any necessary changes to their practice.
CKS Updates May 2020
During the month of May 2020, the following Clinical Knowledge Summaries were published or updated:
The Sprains and strains topic has been restructured and recommendations have been updated in line with current evidence.
Clinicians can use the updated and new information when reviewing patients.
The information in the Prescribing News section has been adapted from the Prescribing Advice for GPs blog www.prescriber.org.uk